1. Home
  2. NKTR vs TG Comparison

NKTR vs TG Comparison

Compare NKTR & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • TG
  • Stock Information
  • Founded
  • NKTR 1990
  • TG 1988
  • Country
  • NKTR United States
  • TG United States
  • Employees
  • NKTR N/A
  • TG N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • NKTR Health Care
  • TG Industrials
  • Exchange
  • NKTR Nasdaq
  • TG Nasdaq
  • Market Cap
  • NKTR 238.7M
  • TG 172.5M
  • IPO Year
  • NKTR 1994
  • TG 1989
  • Fundamental
  • Price
  • NKTR $1.45
  • TG $8.01
  • Analyst Decision
  • NKTR Buy
  • TG
  • Analyst Count
  • NKTR 4
  • TG 0
  • Target Price
  • NKTR $2.50
  • TG N/A
  • AVG Volume (30 Days)
  • NKTR 1.3M
  • TG 103.7K
  • Earning Date
  • NKTR 11-05-2024
  • TG 11-07-2024
  • Dividend Yield
  • NKTR N/A
  • TG N/A
  • EPS Growth
  • NKTR N/A
  • TG N/A
  • EPS
  • NKTR N/A
  • TG N/A
  • Revenue
  • NKTR $93,157,000.00
  • TG $701,507,000.00
  • Revenue This Year
  • NKTR N/A
  • TG N/A
  • Revenue Next Year
  • NKTR N/A
  • TG N/A
  • P/E Ratio
  • NKTR N/A
  • TG N/A
  • Revenue Growth
  • NKTR 6.17
  • TG N/A
  • 52 Week Low
  • NKTR $0.41
  • TG $3.98
  • 52 Week High
  • NKTR $1.93
  • TG $8.54
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 63.84
  • TG 76.34
  • Support Level
  • NKTR $1.27
  • TG $6.97
  • Resistance Level
  • NKTR $1.39
  • TG $8.54
  • Average True Range (ATR)
  • NKTR 0.09
  • TG 0.27
  • MACD
  • NKTR 0.01
  • TG 0.04
  • Stochastic Oscillator
  • NKTR 88.89
  • TG 66.24

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: